Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0P7VJ
|
|||
Former ID |
DIB001594
|
|||
Drug Name |
Pramiracetam
|
|||
Synonyms |
Amacetam; Ectapram; Neupramir; Remen; Amacetam hydrochloride; Amacetam sulfate; Pramiracetam hydrochloride; Pramiracetam sulfate; CNS-1879
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Brain disease [ICD-11: 8C70-8E61; ICD-10: G00-G99] | Approved (orphan drug) | [1] | |
Company |
Warner-Lambert Co
|
|||
Structure |
Download2D MOL |
|||
Formula |
C14H27N3O2
|
|||
Canonical SMILES |
CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C
|
|||
InChI |
1S/C14H27N3O2/c1-11(2)17(12(3)4)9-7-15-13(18)10-16-8-5-6-14(16)19/h11-12H,5-10H2,1-4H3,(H,15,18)
|
|||
InChIKey |
ZULJGOSFKWFVRX-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 68497-62-1
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:135110
|
References | Top | |||
---|---|---|---|---|
REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
REF 2 | Some neurochemical properties of pramiracetam (CI-879), a new cognition-enhancing agent. Article first published online: 5 OCT 2004. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.